Nasal route favors the induction of CD4 + T cell responses in the liver of HBV-carrier mice immunized with a recombinant hepatitis B surface- and core-based therapeutic vaccine
Author:
Funder
Cuba-France cooperation
Publisher
Elsevier BV
Subject
Virology,Pharmacology
Reference41 articles.
1. Development of a nasal vaccine for chronic hepatitis B infection that uses the ability of hepatitis B core antigen to stimulate a strong Th1 response against hepatitis B surface antigen;Aguilar;Immunol Cell Biol.,2004
2. Therapeutic potential of a combined hepatitis B virus surface and core antigen vaccine in patients with chronic hepatitis B;Al-Mahtab;Hepatol Int.,2013
3. A phase III clinical trial with a nasal vaccine containing both HBsAg and HBcAg in patients with chronic hepatitis B;Al-Mahtab;J Hepatol.,2013
4. An evidence-based therapy for chronic hepatitis B using HBV-related multiple antigens that control HBV replication and protects liver damage;Al-Mahtab;Hepatol Int.,2013
5. Protein-prime/modified vaccinia virus Ankara vector-boost vaccination overcomes tolerance in high-antigenemic HBV-transgenic mice;Backes;Vaccine,2016
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Mafosfamide Boosts GMI-HBVac against HBV via Treg Depletion in HBV-Infected Mice;Vaccines;2023-05-25
2. Action Mechanisms and Scientific Rationale of Using Nasal Vaccine (HeberNasvac) for the Treatment of Chronic Hepatitis B;Vaccines;2022-12-07
3. Innovative Therapies Targeting the Virus and the Host for Treating Chronic Hepatitis B Virus Infection: From Bench to Bedside;Vaccines;2022-05-10
4. A broad-spectrum nanobody targeting the C-terminus of the hepatitis B surface antigen for chronic hepatitis B infection therapy;Antiviral Research;2022-03
5. Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models;Cell Host & Microbe;2021-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3